Tag: BioSig

BioSig Technologies Announces FDA 510(k) Clearance for PURE EP System

Santa Monica, CA, Aug. 14, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), announced that the Company has received 510(k) clearance for its first product, PURE EP System, from the U.S. Food and Drug Administration (FDA). The non-invasive PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring […]

BioSig Technologies Completes Private Placement

Santa Monica, CA, Aug. 13, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company closed a private placement of $4,281,000. Combined with the […]

BioSig Technologies Ranked Top 50 for The Silicon Review’s Innovative Companies to Watch in 2018

Santa Monica, CA, July 24, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, was featured in The Silicon Review’s list of Top 50 Innovative […]

BioSig Technologies to Present at the 40th International Conference of the IEEE Engineering in Medicine and Biology Society

Santa Monica, CA, July 11, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the research poster entitled “Unipolar Intracardiac Signal Morphology as a […]

BioSig Technologies to Present at the Emerging Medical Technologies Spotlight

Santa Monica, CA, June 29, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that it will be presenting at the Q2 2018 Emerging Medical […]

BioSig Technologies to Partner with High Lantern Group

Santa Monica, CA, April 26, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform for the $4.6 billion electrophysiology (EP) marketplace, today announced that it has appointed High Lantern Group (HLG) to assist in building a global stakeholder engagement strategy as the […]

BioSig Technologies Appoints New CFO to Facilitate Growth Trajectory

Santa Monica, CA, Jan. 03, 2018 (GLOBE NEWSWIRE) — BioSig Technologies(OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that Mr. Steven (Steve) Chaussy will be joining the company to serve in […]